On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
Departed
Nancy Simonian
Director
Syros Pharmaceuticals, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
Departed
Peter Wirth
Director
Syros Pharmaceuticals, Inc.
Effective
2025-02-28
Filed
February 28, 2025, 6:59 PM ET
On February 28, 2025, each of Peter Wirth, Marsha H. Fanucci, and Nancy Simonian, M.D., notified the Board of such director’s resignation from the Board and all committees or subcommittees thereof, effective immediately.
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
On February 25, 2025, Mark A. Blinn and Manuel A. Fernandez each notified the Company of their respective decisions to retire as a director of the Company effective immediately prior to the beginning of the 2025 annual shareholder meeting, which currently is expected to be held on May 7, 2025.
Departed
Adam Gallistel
Director
STORE CAPITAL LLC
Effective
2025-02-24
Filed
February 28, 2025, 6:59 PM ET
Effective February 24, 2025, each of Adam Gallistel and Michael Reiter resigned from all positions that he held at STORE Capital LLC (the “ Company ”) and its subsidiaries, including as a member of the Board of Directors (the “ Board ”).
Departed
Michael Reiter
Director
STORE CAPITAL LLC
Effective
2025-02-24
Filed
February 28, 2025, 6:59 PM ET
Effective February 24, 2025, each of Adam Gallistel and Michael Reiter resigned from all positions that he held at STORE Capital LLC (the “ Company ”) and its subsidiaries, including as a member of the Board of Directors (the “ Board ”).
Mr. Tirdad Rouhani is no longer President of Ispire Technology Inc. (the “Company”) or otherwise employed by the Company or any of the Company’s subsidiaries or affiliates, effective February 27, 2025.
Departed
Ralph Schiess
Interim Chief Executive Officer and Chief Science Officer
On February 24, 2025, Dr. Ralph Schiess resigned from his positions as the Interim Chief Executive Officer and Chief Science Officer of Onconetix, Inc. (the “Company”), effective immediately
Departed
Todd Becker
President and Chief Executive Officer and member of the Board of Directors
On February 28, 2025, the Board of Directors of Green Plains Inc. (the “Company”) announced by press release the departure of Todd Becker as President and Chief Executive Officer and member of the Board of Directors (the “Board”) of the Company, effective March 1, 2025.
he will not stand for reelection as a director of the Company and as Chairman of the Board and a director of the Bank upon the completion of his current term on the Company’s and the Bank’s boards of directors on April 17, 2025
Departed
Melanie M. Kennedy
Executive Vice President and Chief Human Resources Officer
On February 28, 2025 , the Executive Development and Compensation Committee of the Board of Directors of American Water Works Company, Inc. (the “Company”) unanimously approved a Severance Agreement and General Release (the “Severance Agreement”) to be entered into between Melanie M. Kennedy, the Company’s Executive Vice President and Chief Human Resources Officer, and American Water Works Service Company, Inc., a wholly owned subsidiary of the Company and Ms. Kennedy’s employer.
On February 24, 2025, HealthStream, Inc. (the “Company”) received notice that Michael Sousa, Executive Vice President, Enterprise Applications intends to resign from his current position at the Company effective March 31, 2025.
On February 28, 2025, Associated Capital Group, Inc. (the “Company”) announced that Douglas R. Jamieson will be retiring as its Chief Executive Officer and President effective March 17, 2025, and will continue in his role as a Director of the Company.
On February 28, 2025, Arnold Tinter resigned as a director and corporate secretary of the Company and its subsidiaries due to his desire to retire from active business pursuits.
On February 26, 2025, Lim P. Nguonly, a director of John Marshall Bancorp, Inc. (the “Company”) and John Marshall Bank (the “Bank”), a wholly-owned subsidiary of the Company, notified the Company and the Bank that he will not stand for re-election to the Board of Directors of the Company at its 2025 annual meeting of shareholders and will retire from the Boards of Directors of the Company and the Bank effective at the conclusion of the next Board of Directors meeting to be held on March 18, 2025.
On February 24, 2025, Rory Riggs resigned as the Chief Executive Officer of Cibus, Inc.
Departed
Dawn Smajstrla
Chief Accounting Officer
Sitio Royalties Corp.
Effective
2025-02-27
Filed
February 28, 2025, 6:59 PM ET
On February 27, 2025, Dawn Smajstrla ceased to serve as Chief Accounting Officer of Sitio Royalties Corp.
Departed
Anthony Querciagrossa
Chief Financial Officer
Pinstripes Holdings, Inc.
Effective
2025-02-28
Successor
Caitlin Schaefer
Filed
February 28, 2025, 6:59 PM ET
As previously reported, on February 17, 2025, Anthony Querciagrossa informed the Board of Directors (the “Board”) of Pinstripes Holdings, Inc. (the “Company”) of his resignation as Chief Financial Officer of the Company, effective February 28, 2025.
Departed
Thomas E. Powell
Executive Vice President and Chief Financial Officer
who on February 24, 2025 informed the Company that he will retire as Executive Vice President and Chief Financial Officer of the Company, effective April 1, 2025.
On February 26, 2025, Ziv Shoshani resigned from the Board of Directors of Vishay Intertechnology, Inc. ("the Company"), effective immediately before the election of directors at the Company’s annual meeting of stockholders on May 20, 2025, in order to devote his full business time and attention to Vishay Precision Group, Inc., which he serves as President and Chief Executive Officer and as a member of the board.
On February 26, 2025, Mary T. McDowell informed the Board of her intention not to stand for re-election at Autodesk's 2025 Annual Meeting of Stockholders.
On February 27, 2025, Cisco and Gary Steele, President, Go-to-Market of Cisco, agreed to change the effective date of his previously announced resignation from Cisco to May 12, 2025.
the Company is reporting that Doug Miller, the Company’s President and Chief Commercial Officer is departing from the Company to pursue other opportunities.
On February 24, 2025, Ms. Sherry Aulin notified the Company of her decision to resign as Chief Financial Officer, effective June 30, 2025, for personal reasons.
On February 24, 2025, Bill Wagner, a member of the Board of Directors (the “Board”) of Akamai Technologies, Inc. (the “Company”), notified the Company of his intent to resign from the Board, effective immediately, due to his acceptance of a new role as Chief Executive Officer of Semrush Holdings, Inc.
On February 24, Leigh Morgan, a member of the Board of Directors (the “Board”) of the Company, the Compensation and Talent Committee of the Board, and a member and chair of the Nominating and Corporate Governance Committee of the Board, informed the Company that she does not intend to stand for reelection at the Company’s 2025 annual meeting of shareholders.
On February 25, 2025, Ignacio Alvarez announced his retirement as Chief Executive Officer (“CEO”) of Popular, Inc. (“Popular” or the “Corporation”), effective June 30, 2025 (the “Retirement Date”).
Departed
David McJannet
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Paul Warenski
Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed
David Henshall
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
David McJannet
Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed
Sigal Zarmi
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Glenn Solomon
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Susan St. Ledger
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Armon Memaran-Dadgar
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Werner Schwok
Other Named Officer
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Paul Warenski and Werner Schwok, each of whom was an officer of HashiCorp as of immediately prior to the Effective Time, ceased to be an officer of HashiCorp
Departed
Todd Ford
Director
HashiCorp, Inc.
Effective
2025-02-27
Filed
February 27, 2025, 6:59 PM ET
David McJannet, Armon Memaran-Dadgar, Glenn Solomon, Susan St. Ledger, Todd Ford, Sigal Zarmi and David Henshall, each of whom was a director of HashiCorp as of immediately prior to the Effective Time, ceased to be a director of HashiCorp
Departed
Andrew Spaventa
Chair of the Board
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed
Andrew Spaventa
Chief Executive Officer and Chair of the Board
Singular Genomics Systems, Inc.
Effective
2025-02-21
Successor
Joshua Stahl
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed
Dalen Meeter
Chief Financial Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Departed
Eli Glezer
Chief Scientific Officer
Singular Genomics Systems, Inc.
Effective
2025-02-21
Filed
February 27, 2025, 6:59 PM ET
Each of Andrew Spaventa, the Company’s Chief Executive Officer and Chair of the Company’s Board, Eli Glezer, Ph.D., the Company’s Chief Scientific Officer and Dalen Meeter, the Company’s Chief Financial Officer resigned from the Company, effective as of immediately prior to the Effective Time.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.